How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?
Transfusion · 2026
DOI: 10.1111/trf.70388 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, 2026. Verfasst von Leisa Bruneau und 11 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance and Discovery Laboratory, Canadian Blood Services, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Blood Safety, Communicable Diseases, Blood Transfusion. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Blood Services.
Abstract (Originalsprache)
Background
Public access to up‐to‐date information on infectious diseases and outbreaks has grown rapidly with the advent of artificial intelligence platforms. While this information can improve patient care and support research, the sheer volume of available data coupled with the challenge of identifying misinformation and disinformation can be overwhelming. A key challenge is managing large information volumes and identifying early, subtle signals that may indicate risks or opportunities to prevent infection. The aim of this manuscript is to explain how a national blood operator identifies and evaluates subtle infectious disease signals generated by horizon scanning to proactively protect the blood supply, including biotherapy products.
Methods
Horizon scanning protocols were developed to detect early signals of change (emerging/re‐emerging pathogens, geopolitical/environmental changes, scientific and technological advances, new therapies/treatments for infectious diseases, and blood operator transfusion medicine changes). Communication strategies were created to alert national and international transfusion medicine decision makers of blood safety‐related events.
Results
Several key components of a horizon scanning approach are presented to illustrate how novel information can be identified, processed, and formulated into knowledge translation products. Efficient and cost‐effective approaches are presented to enable horizon scanning activities with limited resources and time commitments.
Discussion
Horizon scanning is an efficient and necessary activity to safeguard the blood supply. Here we present a collaborative group‐based approach, which reduces operator bias and improves overall examination of multiple data sources. This approach does not require expensive technology, can focus on open‐source information, and engages new scientists in learning about infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surveillance and Discovery Laboratory, Canadian Blood Services, Ottawa, Ontario, Canada.
- Medical Microbiology, Innovation, Canadian Blood Services, Ottawa, Ontario, Canada.
- Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
- Transplant & Cellular Therapy, Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
- Stem Cells, Canadian Blood Services, Ottawa, Ontario, Canada.
ORCID-Profile: Carmen L Charlton, Sandra Ramirez-Arcos, David Allan, Evan M Bloch, Chantale Pambrun, Sheila F O'Brien, Steven J Drews
Förderung
- Canadian Blood Services
Zitieren
APA
Bruneau, L., Charlton, C. L., Ramirez-Arcos, S., Kumaran, D., Allan, D., Norman, O., Seftel, M., Bloch, E. M., Pambrun, C., O'Brien, S. F., Cranney, C., & Drews, S. J. (2026). How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?. Transfusion. https://doi.org/10.1111/trf.70388
Vancouver
Bruneau L, Charlton CL, Ramirez-Arcos S, Kumaran D, Allan D, Norman O, et al. How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?. Transfusion. 2026. doi:10.1111/trf.70388
BibTeX
@article{Bruneau2026,
author = {Bruneau, Leisa and Charlton, Carmen L and Ramirez-Arcos, Sandra and Kumaran, Dilini and Allan, David and Norman, Olivia and Seftel, Matthew and Bloch, Evan M and Pambrun, Chantale and O'Brien, Sheila F and Cranney, Cynthia and Drews, Steven J},
title = {How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70388}
}
EUVIMED